Allstocks.com's Bulletin Board Post New Topic  Post A Reply
my profile login | register | search | faq | forum home

  next oldest topic   next newest topic
» Allstocks.com's Bulletin Board » NASDAQ, AMEX, NYSE Stocks » CBLI - Cleveland BioLabs, Inc.

 - UBBFriend: Email this page to someone!    
Author Topic: CBLI - Cleveland BioLabs, Inc.
DallasInvestor
Member


Rate Member
Icon 1 posted      Profile for DallasInvestor     Send New Private Message       Edit/Delete Post   Reply With Quote 
CBLI Earns “Buy” Rating

CBLI Earns “Buy” Rating from WBB Securities, LLC

Regarding Cleveland BioLabs's radiation protection platform, the analyst observed that the Company’s commercial opportunities fall into two primary categories.

The first is the HHS (Department of Health and Human Services) and BARDA (Biomedical Advanced Research and Development Authority) category, which deals with unintended radiation exposure. He stated that the Company has a unique opportunity to address radiation exposure, since there are not currently any existing products available that offer meaningful solutions.

In addition, the analyst noted the Company's potential for traditional medical indications for the same technology.

Posts: 56 | From: Dallas, TX | Registered: Oct 2006  |  IP: Logged | Report this post to a Moderator
DallasInvestor
Member


Rate Member
Icon 1 posted      Profile for DallasInvestor     Send New Private Message       Edit/Delete Post   Reply With Quote 
Latest CBLI Video Podcast Now Showing on Firestocks.com

In addition to highlighting recent developments at the Company, the interview featured commentary from Stephen Brozak of WBB Securities, LLC that recently initiated coverage of Cleveland BioLabs with a Buy rating.

Cleveland BioLabs, Inc. is a drug discovery and development company leveraging its proprietary discoveries about programmed cell death to treat cancer and protect normal tissues from exposure to radiation and other stresses.

The Company has strategic partnerships with the Cleveland Clinic Foundation, Roswell Park Cancer Institute, ChemBridge Corporation and the Armed Forces Research Radiobiology Institute.

Posts: 56 | From: Dallas, TX | Registered: Oct 2006  |  IP: Logged | Report this post to a Moderator
DallasInvestor
Member


Rate Member
Icon 1 posted      Profile for DallasInvestor     Send New Private Message       Edit/Delete Post   Reply With Quote 
Several New Developments Send Strong Signal

Four Company Developments Have Strong Potential
A successful response to the DOD's RFP and further development of Protectan CBLB502, which the Company forecasts to generate revenues in 2008

The launch of additional Phase II clinical trials for Curaxin CBLC102

The progress of their potential stem cell applications from research, to clinical development

The movement of their radiation protection compounds into human studies, in new therapeutic areas, such as supportive care for cancer and acute organ failure.

Posts: 56 | From: Dallas, TX | Registered: Oct 2006  |  IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is not enabled.
UBB Code™ is enabled.

Instant Graemlins
   


Post New Topic  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share